Drug Enforcement Administration (DEA) Administrative Law Judge (ALJ) John Mulrooney has cancelled the long-awaited cannabis re-scheduling hearing set for next week. Pro-reform advocates have suggested that the DEA had...more
1/15/2025
/ Administrative Law Judge (ALJ) ,
Administrative Procedure Act ,
Appeals ,
DEA ,
Decriminalization of Marijuana ,
Deregulation ,
Legalization ,
Marijuana ,
Regulatory Agenda ,
Regulatory Reform ,
Rulemaking Process
Cannabis would move to Schedule III from Schedule I under this reclassification. In a move long awaited by the cannabis industry, the Drug Enforcement Administration (DEA) has decided to re-schedule cannabis. Currently...more
The Blunt Truth® has long covered the intersection of alcohol and cannabis. For example, just last month we explored the potential for regulatory confusion that might ensue if states begin allowing the sale of cannabis in...more
It has already been a busy year for marijuana law! Catch up on key legislative, regulatory, and legal developments affecting the manufacture, distribution, sale, and use of marijuana occurring in 2022, including key decisions...more
Happy New Year and welcome back as The Blunt Truth begins its seventh year of publication. ...more
If you are in the cannabis industry, you should already know Section 280E of the Internal Revenue Code. It consists of only one sentence...more
1/31/2020
/ Agribusiness ,
Audits ,
Business Development ,
Business Expenses ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances ,
Controlled Substances Act ,
Decriminalization of Marijuana ,
Hemp ,
Hemp Cultivation ,
Hemp Related Businesses ,
Income Taxes ,
Internal Revenue Code (IRC) ,
IRC Section 280E ,
IRS ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Retail Market ,
Tax Deductions ,
Tax Liability ,
Tax Planning
Marijuana is estimated to be a $10 billion industry and rapidly growing. Almost all of it is conducted in cash. Although legal in thirty three states plus Washington, D.C., Puerto Rico and Guam, marijuana remains illegal at...more
5/7/2019
/ Banking Regulators ,
Banking Sector ,
Controlled Substances Act ,
Criminal Proceeds ,
Decriminalization of Marijuana ,
Dispensaries ,
Distributors ,
Financial Institutions ,
Financial Services Industry ,
Financial Transactions ,
FinCEN ,
Legislative Agendas ,
Manufacturers ,
Marijuana ,
Marijuana Related Businesses ,
Money Laundering ,
SAFE Act ,
Safe Harbors ,
Suspicious Activity Reports (SARs)
On June 25, 2018, the Food and Drug Administration (“FDA”) approved Epidiolex (cannabidiol), the first marijuana derived drug for use in the United States, to treat two rare forms of epilepsy....more